Tao, Y., et al
Weight loss achieved through these medications often reduces depression and anxiety, which are common in individuals with obesity and can negatively affect sexual function
healthcare professionals, including doctors and nurse practitioners, and offers personalized treatment plans designed to address a variety of health concerns
Targeting IGF-1 signaling pathways in gynecologic malignancies
Metabolic Regulation Studies on glucose metabolism, insulin sensitivity, and glucagon signaling
Drucker has reported receiving fees for consulting, research, and/or speaking from Altimmune, Amgen, Boehringer Ingelheim, Kallyope, Merck, Novo Nordisk, Pfizer, Sanofi, and Zealand